1 Innovations in Care Directorate for Medicine Annual Report 2016
Yüklə 1,12 Mb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Infectious Diseases
Brzezniak, C., Schmitz, B. A., Peterson, P. G., Degesys, A., Oronsky, B. T., Scicinski, J. J., Caroen, S. Z., & Carter, C. A. (2016). RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report.
Carter, C. A., Browning, R., Oronsky, B. T., Scicinski, J. J., & Brzezniak, C. (2016). The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced Pneumonitis. Case Rep Oncol, 9(1), 68-75. doi:10.1159/000443723
Carter, C. A., Oronsky, B., Caroen, S., Scicinski, J., Cabrales, P., Degesys, A., & Brzezniak, C. (2016). Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC. Respir Med Case Rep, 18, 62-65. doi:10.1016/j.rmcr.2016.04.007
Carter, C. A., Oronsky, B. T., Caroen, S. Z., Scicinski, J. J., Cabrales, P., Reid, T., Degesys, A., Jenkins, J., & Brzezniak, C. (2016). Partial Response to Platinum Doublets in Refractory EGFR-Positive Non- Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization. Case Rep Oncol, 9(1), 62-67. doi:10.1159/000443725
Carter, C. A., Oronsky, B. T., Caroen, S. Z., Scicinski, J. J., Degesys, A., Kim, M. M., Oronsky, A. L., Lybeck, H., Cabrales, P., Oronsky, N., Reid, T., Roswarski, J., & Brzezniak, C. (2016). RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets. Case Rep Oncol, 9(1), 171-176. doi:10.1159/000444631
Carter, C. A., Schmitz, B., Peterson, P. G., Quinn, M., Degesys, A., Jenkins, J., Oronsky, B., Scicinski, J., Caroen, S., Reid, T. R., Cabrales, P., & Brzezniak, C. (2016). Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case Rep Oncol, 9(1), 164-170. doi:10.1159/000444633
Carter, C. A., Scicinski, J. J., Lybeck, H. E., & Oronsky, B. T. (2016). Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome? Case Rep Oncol, 9(1), 246-248. doi:10.1159/000446064
Carter, C. A., Zeman, K., Day, R. M., Richard, P., Oronsky, A., Oronsky, N., Lybeck, M., Scicinski, J., & Oronsky, B. (2016). Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies. Oncotarget, 7(26), 40781-40791. doi:10.18632/ oncotarget.8205
Ettinger EA, Paz P,James EA, Gunasekera D, Aswad F, Thompson AR, Matthews DC, Pratt KP. T cells from three hemophilia A subjects recognized the same HLA-restricted FVIII epitope with a narrow TCR repertoire. Blood 128(16):2043-2054. PMID: 27471234
Graff, A. E., Lewis, S. L., Bear, J. R., Van Echo, D. C., & Dainer, H. M. (2016). Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report. Cureus, 8(2), e493. doi:10.7759/cureus.493
Horn, L., Wakelee, H., Reckamp, K. L., Blumenschein, G., Jr., Infante, J. R., Carter, C. A., Waqar, S. N., Neal, J. W., Harrow, K., Gockerman, J. P., Dukart, G., Liang, C., Gibbons, J. L., Hernandez, J., Newman-Eerkes, T., Lim, L., & Lovly, C. M. (2016). MINI01.02: Response and Plasma Genotyping from Phase I/II Trial of Ensartinib (X-396) in Patients (pts) with ALK+ NSCLC: Topic: Medical Oncology. J Thorac Oncol, 11(11s), S256-s257. doi:10.1016/j.jtho.2016.09.017
Lin, J., McGlynn, K. A., Carter, C. A., Nations, J. A., Anderson, W. F., Shriver, C. D., & Zhu, K. (2016). The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System. Cancer Epidemiol Biomarkers Prev, 25(12), 1564-1571. doi:10.1158/1055-9965.epi-16-0316
Mertz, A. T., & Ojemuyiwa, M. A. (2016). A Case of Poorly Differentiated Large-Cell Neuroendocrine Carcinoma of the Cecum: A Rare Malignancy, with Review of the Literature. Case Rep Oncol, 9(3), 847-853. doi:10.1159/000452655
Oronsky, B., Scicinski, J., Kim, M. M., Cabrales, P., Salacz, M. E., Carter, C. A., Oronsky, N., Lybeck, H., Lybeck, M., Larson, C., Reid, T. R., & Oronsky, A. (2016). Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents. Biomolecules, 6(3). doi:10.3390/biom6030032
Aronson N, Herwaldt B, Libman M et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the IDSA and ASTMH. Clin Infect Dis. Dec 2016. Doi:10.1093/cid/ciw670 Bello, K. J., Mesner, O., O'Bryan, T. A., Won, S. H., Lalani, T., Ganesan, A., Agan, B. K., & Okulicz, J. F. (2016). Factors associated with 10 years of continuous viral load suppression on HAART. BMC
Crowell, T. A., Ganesan, A., Berry, S. A., Deiss, R. G., Agan, B. K., & Okulicz, J. F. (2016). Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study. J Int AIDS Soc, 19(1), 20524. doi:10.7448/ias.19.1.20524
Crum-Cianflone, N. F., Won, S., Lee, R., Lalani, T., Ganesan, A., Burgess, T., & Agan, B. K. (2016). Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults. Vaccine, 34(41), 5040-5046. doi:10.1016/j.vaccine.2016.06.019
Decker, C.F. Emerging sexually transmitted diseases: Hepatitis C, lymphogranuloma venereum (LGV) and mycoplasma genitalium infections. Dis Mon. 2016 Aug; 62(8):314-8.
Deiss, R., Bower, R. J., Co, E., Mesner, O., Sanchez, J. L., Masel, J., Ganesan, A., Macalino, G. E., & Agan, B. K. (2016). The Association between Sexually Transmitted Infections, Length of Service and Other Demographic Factors in the U.S. Military. PLoS One, 11(12), e0167892. doi:10.1371/ journal.pone.0167892
Farmer, A., Wang, X., Ganesan, A., Deiss, R. G., Agan, B. K., O'Bryan, T. A., Akers, K., & Okulicz, J. F. (2016). Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study. AIDS Res Ther, 13, 16. doi:10.1186/s12981-016-0100-4
Fiske, L. C., Homeyer, D. C., Zapor, M., Hartzell, J., Warkentien, T., Weintrob, A. C., Ganesan, A., Burgess, T., Snesrud, E., Waterman, P., Nielsen, L., & Ressner, R. A. (2016). Isolation of Rapidly Growing Nontuberculous Mycobacteria in Wounds Following Combat-Related Injury. Mil Med, 181(6), 530-536. doi:10.7205/milmed-d-14-00731
Freiberg, M. S., Bebu, I., Tracy, R., So-Armah, K., Okulicz, J., Ganesan, A., Armstrong, A., O'Bryan, T., Rimland, D., Justice, A. C., & Agan, B. K. (2016). D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non- AIDS Events. PLoS One, 11(4), e0152588. doi:10.1371/journal.pone.0152588
Regules, J.A., Beigel, J.H., Paolino, K.M., Voell, J., Castellano, A.R., Hu, Z., Muñoz, P., Moon, J.E., Ruck, R.C., Bennett, J.W., Twomey, P.S., Gutiérrez, R.L., Remich, S.A., Hack, H.A., Wisniewski, M.L., Joselyn, M.D., Kwilas, S.A., VanDeusen, N., Mbaya, O.T., Zhou, Y., Stanley, D.A., Jing, W., Smith, K.S., Shi, M., Ledgerwood, J.E., Graham, B.S., Sullivan, N.J., Jagodzinski, L.L., Peel, S.A., Alimonti, J.B., Hooper, J.W., Silvera, P.M., Martin, B.K., Monath, T.P., Ramsey, W.J., Link, C.J., Lane, H.C., Michael, N.L., Davey Jr, R.T., Thomas, S.J., and the rVSVΔG-ZEBOV-GP Study Group. Recombinant Vesicular Stomatitis Virus Ebola Vaccine. N Engl J Med, 2017.
Lalani, T., Yun, H., Tribble, D., Ganesan, A., Kunz, A., Fairchok, M., Schnaubelt, E., Fraser, J., Mitra, I., Kronmann, K. C., Burgess, T., Deiss, R. G., Riddle, M. S., & Johnson, M. D. (2016). A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria. J Travel Med, 23 (5). doi:10.1093/jtm/taw043
Masel, J. H., Martell, D. W., Logemann, N. F., & Wilson, K. E. (2016). Nodular Skin Lesions in an Immunocompromised Patient. Clin Infect Dis, 63(8), 1140-1141. doi:10.1093/cid/ciw434 Yüklə 1,12 Mb. Dostları ilə paylaş:
|